Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-amino-6-(s)-lactoyl-7,8-dihydro-4(3h)- Pteridinone
2. 2-amino-7,8-dihydro-6-((2s)-2-hydroxy-1-oxopropyl)-4(3h)-pteridinone Acid
3. 4(3h)-pteridinone, 2-amino-7,8-dihydro-6-((2s)-2-hydroxy-1-oxopropyl)-
4. L-sepiapterin
5. Sepia-pterin
6. Sepiapterin-c
7. Sepiapterine
1. L-sepiapterin
2. 17094-01-8
3. Sepiapterine
4. Sepiapterin [usan]
5. Lopac-s-154
6. Cjq26ko7hp
7. (s)-2-amino-6-(2-hydroxypropanoyl)-7,8-dihydropteridin-4(3h)-one
8. Cnsa-001
9. Ptc923
10. 2-amino-6-(s)-lactoyl-7,8-dihydro-4(3h)-pteridinone
11. 2-amino-6-[(2s)-2-hydroxypropanoyl]-7,8-dihydro-3h-pteridin-4-one
12. 4(3h)-pteridinone, 2-amino-7,8-dihydro-6-((2s)-2-hydroxy-1-oxopropyl)-
13. Unii-cjq26ko7hp
14. 4(3h)-pteridinone, 2-amino-7,8-dihydro-6-[(2s)-2-hydroxy-1-oxopropyl]-
15. 4(3h)-pteridinone,2-amino-7,8-dihydro-6-[(2s)-2-hydroxy-1-oxopropyl]-
16. Sepiapterin, Solid
17. Sepiapterin [inn]
18. Lopac0_001123
19. 6-lactoyl-7,8-dihydropterin
20. Mls002153268
21. Schembl258399
22. Chembl1255653
23. Dtxsid40937902
24. Ptc-923
25. Hms2234o10
26. Hms3263b07
27. Tox21_501123
28. 2-amino-6-[(2s)-2-hydroxypropanoyl]-7,8-dihydro-1h-pteridin-4-one
29. Who 11848
30. Zinc17721961
31. Akos022181294
32. Ccg-205198
33. Lp01123
34. Sdccgsbi-0051091.p002
35. Ncgc00015913-01
36. Ncgc00094391-01
37. Ncgc00094391-02
38. Ncgc00094391-03
39. Ncgc00094391-05
40. Ncgc00261808-01
41. Smr001230707
42. Hy-112234
43. Cs-0044215
44. Eu-0101123
45. S-154
46. C00835
47. Sr-01000075522
48. Q2271580
49. Sr-01000075522-1
50. (s)-2-amino-6-(2-hydroxypropanoyl)-7,8-dihydropteridin-4(1h)-one
51. (s)-2-amino-7,8-dihydro-6-(2-hydroxy-1-oxopropyl)-4(1h)-pteridinone
52. 1-(2-amino-7,8-dihydro-4-hydroxy-6-pteridinyl)-2-hydroxy-1-propanone
53. 2-amino-6-[(2s)-2-hydroxypropanoyl]-1,4,7,8-tetrahydropteridin-4-one
54. 2-amino-7,8-dihydro-6-[(2s)-2-hydroxy-1-oxopropyl]-4(1h)pteridinone
55. S(-)-2-amino-7,8-dihydro-6-(2-hydroxy-1-oxopropyl)-4(1h)-pteridione
56. 2-amino-7,8-dihydro-6-((2s)-2-hydroxy-1-oxopropyl)-4(3h)-pteridinone
57. 4(1h)-pteridinone, 2-amino-7,8-dihydro-6-(2-hydroxy-1-oxopropyl)-, (s)-
| Molecular Weight | 237.22 g/mol |
|---|---|
| Molecular Formula | C9H11N5O3 |
| XLogP3 | -2 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 2 |
| Exact Mass | 237.08618923 g/mol |
| Monoisotopic Mass | 237.08618923 g/mol |
| Topological Polar Surface Area | 129 Ų |
| Heavy Atom Count | 17 |
| Formal Charge | 0 |
| Complexity | 491 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Sepiapterin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sepiapterin, including repackagers and relabelers. The FDA regulates Sepiapterin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sepiapterin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sepiapterin supplier is an individual or a company that provides Sepiapterin active pharmaceutical ingredient (API) or Sepiapterin finished formulations upon request. The Sepiapterin suppliers may include Sepiapterin API manufacturers, exporters, distributors and traders.
Sepiapterin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sepiapterin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sepiapterin GMP manufacturer or Sepiapterin GMP API supplier for your needs.
A Sepiapterin CoA (Certificate of Analysis) is a formal document that attests to Sepiapterin's compliance with Sepiapterin specifications and serves as a tool for batch-level quality control.
Sepiapterin CoA mostly includes findings from lab analyses of a specific batch. For each Sepiapterin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sepiapterin may be tested according to a variety of international standards, such as European Pharmacopoeia (Sepiapterin EP), Sepiapterin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sepiapterin USP).
LOOKING FOR A SUPPLIER?
